Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Schmalzing

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Chest|August 15, 2023
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic SclerosisPia Moinzadeh, Francesco Bonella, Max Oberste, et al.
BMJ Open|March 19, 2021
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocolJulia Spierings, Anna van Rhenen, Paco Mw Welsing, et al.
Transplantation and Cellular Therapy|June 6, 2022
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task ForceGeoffrey D E Cuvelier, Michelle Schoettler, Nataliya P Buxbaum, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisPia Moinzadeh, Elisabeth Aberer, Keihan Ahmadi-Simab, et al.
The Journal of Allergy and Clinical Immunology|January 1, 2023
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung diseaseBas Smits, Sigune Goldacker, Suranjith Seneviratne, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Chest|August 15, 2023
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic SclerosisPia Moinzadeh, Francesco Bonella, Max Oberste, et al.
BMJ Open|March 19, 2021
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocolJulia Spierings, Anna van Rhenen, Paco Mw Welsing, et al.
Transplantation and Cellular Therapy|June 6, 2022
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task ForceGeoffrey D E Cuvelier, Michelle Schoettler, Nataliya P Buxbaum, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisPia Moinzadeh, Elisabeth Aberer, Keihan Ahmadi-Simab, et al.
The Journal of Allergy and Clinical Immunology|January 1, 2023
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung diseaseBas Smits, Sigune Goldacker, Suranjith Seneviratne, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Pageof 14